Liu Ruiwu, Li Xiaocen, Lam Kit S
Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA 95817, USA; University of California Davis Comprehensive Cancer Center, Sacramento, CA 95817, USA.
Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA 95817, USA; University of California Davis Comprehensive Cancer Center, Sacramento, CA 95817, USA; Division of Hematology & Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA 95817, USA.
Curr Opin Chem Biol. 2017 Jun;38:117-126. doi: 10.1016/j.cbpa.2017.03.017. Epub 2017 May 8.
Several combinatorial methods have been developed to create focused or diverse chemical libraries with a wide range of linear or macrocyclic chemical molecules: peptides, non-peptide oligomers, peptidomimetics, small-molecules, and natural product-like organic molecules. Each combinatorial approach has its own unique high-throughput screening and encoding strategy. In this article, we provide a brief overview of combinatorial chemistry in drug discovery with emphasis on recently developed new technologies for design, synthesis, screening and decoding of combinatorial library. Examples of successful application of combinatorial chemistry in hit discovery and lead optimization are given. The limitations and strengths of combinatorial chemistry are also briefly discussed. We are now in a better position to truly leverage the power of combinatorial technologies for the discovery and development of next-generation drugs.
肽、非肽寡聚物、拟肽、小分子和天然产物样有机分子。每种组合方法都有其独特的高通量筛选和编码策略。在本文中,我们简要概述了药物发现中的组合化学,重点介绍了最近开发的用于组合文库设计、合成、筛选和解码的新技术。给出了组合化学在命中发现和先导优化中成功应用的例子。还简要讨论了组合化学的局限性和优势。我们现在处于一个更好的位置,能够真正利用组合技术的力量来发现和开发下一代药物。